Non-classical regulation of estrogen receptor-α by ICI182,780

Journal of Steroid Biochemistry and Molecular Biology

Volumn 92, Issue 1-2, 2004, Pages 51-62

  Wang, Michael M ^a   Traystman, Richard J ^b   Hurn, Patricia D ^b   Liu, Tongyun ^c  

^a UNIVERSITY OF MICHIGAN   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^c JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

AP 1; CRE; Estrogen receptor alpha; ICI182,780; Leptomycin; Non classical; SRE

Indexed keywords

ANTIESTROGEN; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; ESTROGEN RECEPTOR ALPHA; FULVESTRANT; LEPTOMYCIN B; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR AP 1; TRANSCRIPTION FACTOR AP 2; TRANSCRIPTION FACTOR ELK 1;

ARTICLE; CONTROLLED STUDY; CYCLIC AMP RESPONSIVE ELEMENT; HUMAN; HUMAN CELL; POINT MUTATION; PROTEIN DOMAIN; SERUM RESPONSIVE ELEMENT;

CELL LINE; CELL LINE, TUMOR; DOSE-RESPONSE RELATIONSHIP, DRUG; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR MODULATORS; FATTY ACIDS, UNSATURATED; HUMANS; PHOSPHORYLATION; POINT MUTATION; PROTEIN STRUCTURE, TERTIARY; RESPONSE ELEMENTS; TRANS-ACTIVATION (GENETICS); TRANSCRIPTION FACTORS;

CERVUS ELAPHUS;

EID: 8444226480     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jsbmb.2004.06.002     Document Type: Article

References (40)

1. M. Sabbah, D. Courilleau, J. Mester, and G. Redeuilh Estrogen induction of the cyclin D1 promoter: involvement of a cAMP response-like element Proc. Natl. Acad. Sci. U.S.A. 96 1999 11217 11222
2. E. Castro-Rivera, I. Samudio, and S. Safe Estrogen regulation of cyclin D1 gene expression in ZR-75 breast cancer cells involves multiple enhancer elements J. Biol. Chem. 276 2001 30853 30861
3. W. Xing, and T.K. Archer Upstream stimulatory factors mediate estrogen receptor activation of the cathepsin D promoter Mol. Endocrinol. 12 1998 1310 1321
4. M. Stoner, F. Wang, and M. Wormke Inhibition of vascular endothelial growth factor expression in HEC1A endometrial cancer cells through interactions of estrogen receptor alpha and Sp3 proteins J. Biol. Chem. 275 2000 22769 22779
5. W. Wang, L. Dong, B. Saville, and S. Safe Transcriptional activation of E2F1 gene expression by 17beta-estradiol in MCF-7 cells is regulated by NF-Y-Sp1/estrogen receptor interactions Mol. Endocrinol. 13 1999 1373 1387
6. B. Stein, and M.X. Yang Repression of the interleukin-6 promoter by estrogen receptor is mediated by NF-kappa B and C/EBP beta Mol. Cell. Biol. 15 1995 4971 4979
7. R. Galien, and T. Garcia Estrogen receptor impairs interleukin-6 expression by preventing protein binding on the NF-kappaB site Nucleic Acids Res. 25 1997 2424 2429
8. S. Kurebayashi, Y. Miyashita, T. Hirose, S. Kasayama, S. Akira, and T. Kishimoto Characterization of mechanisms of interleukin-6 gene repression by estrogen receptor J. Steroid Biochem. Mol. Biol. 60 1997 11 17
9. M.P. Gaub, M. Bellard, I. Scheuer, P. Chambon, and P. Sassone-Corsi Activation of the ovalbumin gene by the estrogen receptor involves the fos-jun complex Cell 63 1990 1267 1276
10. P. Webb, G.N. Lopez, R.M. Uht, and P.J. Kushner Tamoxifen activation of the estrogen receptor/AP-1 pathway: potential origin for the cell-specific estrogen-like effects of antiestrogens Mol. Endocrinol. 9 1995 443 456
11. R.M. Uht, C.M. Anderson, P. Webb, and P.J. Kushner Transcriptional activities of estrogen and glucocorticoid receptors are functionally integrated at the AP-1 response element Endocrinology 138 1997 2900 2908
12. Y. Umayahara, R. Kawamori, and H. Watada Estrogen regulation of the insulin-like growth factor I gene transcription involves an AP-1 enhancer J. Biol. Chem. 269 1994 16433 16442
13. C. Teyssier, K. Belguise, F. Galtier, and D. Chalbos Characterization of the physical interaction between estrogen receptor alpha and JUN proteins J. Biol. Chem. 276 2001 36361 36369
14. P.J. Kushner, D.A. Agard, and G.L. Greene Estrogen receptor pathways to AP-1 J. Steroid Biochem. Mol. Biol. 74 2000 311 317
15. P. Webb, P. Nguyen, and P.J. Kushner Differential SERM effects on corepressor binding dictate ERalpha activity in vivo J. Biol. Chem. 278 2003 6912 6920
16. M. Jakacka, M. Ito, J. Weiss, P.Y. Chien, B.D. Gehm, and J.L. Jameson Estrogen receptor binding to DNA is not required for its activity through the nonclassical AP1 pathway J. Biol. Chem. 276 2001 13615 13621
17. B.A. Ince, Y. Zhuang, C.K. Wrenn, D.J. Shapiro, and B.S. Katzenellenbogen Powerful dominant negative mutants of the human estrogen receptor J. Biol. Chem. 268 1993 14026 14032
18. C.K. Wrenn, and B.S. Katzenellenbogen Structure-function analysis of the hormone binding domain of the human estrogen receptor by region-specific mutagenesis and phenotypic screening in yeast J. Biol. Chem. 268 1993 24089 24098
19. K.E. Weis, K. Ekena, J.A. Thomas, G. Lazennec, and B.S. Katzenellenbogen Constitutively active human estrogen receptors containing amino acid substitutions for tyrosine 537 in the receptor protein Mol. Endocrinol. 10 1996 1388 1398
20. R. White, M. Sjoberg, E. Kalkhoven, and M.G. Parker Ligand-independent activation of the oestrogen receptor by mutation of a conserved tyrosine EMBO J. 16 1997 1427 1435
21. L. Amazit, Y. Alj, and R.K. Tyagi Subcellular localization and mechanisms of nucleocytoplasmic trafficking of steroid receptor coactivator-1 J. Biol. Chem. 278 2003 32195 32203
22. M.S. Qutob, R.N. Bhattacharjee, E. Pollari, S.P. Yee, and J. Torchia Microtubule-dependent subcellular redistribution of the transcriptional coactivator p/CIP Mol. Cell. Biol. 22 2002 6611 6626
23. E. Jacinto, G. Werlen, and M. Karin Cooperation between Syk and Rac1 leads to synergistic JNK activation in T lymphocytes Immunity 8 1998 31 41
24. A. Minden, A. Lin, and M. McMahon Differential activation of ERK and JNK mitogen-activated protein kinases by Raf-1 and MEKK Science 266 1994 1719 1723
25. R. Metivier, A. Stark, and G. Flouriot A dynamic structural model for estrogen receptor-alpha activation by ligands, emphasizing the role of interactions between distant A and E domains Mol. Cell 10 2002 1019 1032
26. J.D. Norris, D. Fan, M.R. Stallcup, and D.P. McDonnell Enhancement of estrogen receptor transcriptional activity by the coactivator GRIP-1 highlights the role of activation function 2 in determining estrogen receptor pharmacology J. Biol. Chem. 273 1998 6679 6688
27. P. Webb, P. Nguyen, and C. Valentine The estrogen receptor enhances AP-1 activity by two distinct mechanisms with different requirements for receptor transactivation functions Mol. Endocrinol. 13 1999 1672 1685
28. X. Zhang, M. Jeyakumar, S. Petukhov, and M.K. Bagchi A nuclear receptor corepressor modulates transcriptional activity of antagonist-occupied steroid hormone receptor Mol. Endocrinol. 12 1998 513 524
29. A.M. Bamberger, C.M. Bamberger, B. Gellersen, and H.M. Schulte Modulation of AP-1 activity by the human progesterone receptor in endometrial adenocarcinoma cells 93 1996 6169 6174
30. H.M. Reichardt, K.H. Kaestner, and J. Tuckermann DNA binding of the glucocorticoid receptor is not essential for survival Cell 93 1998 531 541
31. M. Jakacka, M. Ito, F. Martinson, T. Ishikawa, E.J. Lee, and J.L. Jameson An estrogen receptor (ER)alpha deoxyribonucleic acid-binding domain knock-in mutation provides evidence for nonclassical ER pathway signaling in vivo Mol. Endocrinol. 16 2002 2188 2201
32. D.B. Lubahn, J.S. Moyer, T.S. Golding, J.F. Couse, K.S. Korach, and O. Smithies Alteration of reproductive function but not prenatal sexual development after insertional disruption of the mouse estrogen receptor gene Proc. Natl. Acad. Sci. U.S.A. 90 1993 11162 11166
33. J. Frasor, J.M. Danes, B. Komm, K.C. Chang, C.R. Lyttle, and B.S. Katzenellenbogen Profiling of estrogen up- and down-regulated gene expression in human breast cancer cells: insights into gene networks and pathways underlying estrogenic control of proliferation and cell phenotype Endocrinology 144 2003 4562 4574
34. M. Sawada, N.J. Alkayed, and S. Goto Estrogen receptor antagonist ICI182, 780 exacerbates ischemic injury in female mouse J. Cereb. Blood Flow Metab. 20 2000 112 118
35. D.D. Yang, C.Y. Kuan, and A.J. Whitmarsh Absence of excitotoxicity- induced apoptosis in the hippocampus of mice lacking the Jnk3 gene Nature 389 1997 865 870
36. H. Huynh, X.F. Yang, and M. Pollak A role for insulin-like growth factor binding protein 5 in the antiproliferative action of the antiestrogen ICI 182780 Cell Growth Differ. 7 1996 1501 1506
37. H. Huynh, X. Yang, and M. Pollak Estradiol and antiestrogens regulate a growth inhibitory insulin-like growth factor binding protein 3 autocrine loop in human breast cancer cells J. Biol. Chem. 271 1996
38. K. Smolnikar, S. Loffek, T. Schulz, H. Michna, and P. Diel Treatment with the pure antiestrogen faslodex (ICI 182780) induces tumor necrosis factor receptor 1 (TNFR1) expression in MCF-7 breast cancer cells Breast Cancer Res. Treat. 63 2000 249 259
39. A. Inoue, N. Yoshida, and Y. Omoto Development of cDNA microarray for expression profiling of estrogen-responsive genes J. Mol. Endocrinol. 29 2002 175 192
40. J. Hur, J. Chesnes, and K.R. Coser The Bik BH3-only protein is induced in estrogen-starved and antiestrogen-exposed breast cancer cells and provokes apoptosis Proc. Natl. Acad. Sci. U.S.A. 101 2004 2351 2356